Company Filing History:
2 out of 2 
2 out of 415 
2 out of 7 
Years Active: 2002-2013
Title: The Innovative Contributions of Moulay Alaoui-Jamali
Introduction
Moulay Alaoui-Jamali is a notable inventor based in Laval, Canada. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. With a total of 4 patents, his work focuses on the creation of compounds that have the potential to treat various forms of cancer and neurodegenerative disorders.
Latest Patents
One of his latest patents involves substituted imidazole derivatives and methods of use for treating cancer. This patent discloses compounds of a general formula that can be used in compositions to treat or prevent cancer and inhibit tumor tissue growth. These compounds are designed to attenuate oxidative damage associated with increased heme-oxygenase activity and can reduce cell proliferation in transformed cells. Additionally, the described compounds and compositions serve as neuroprotectants and are useful for treating or preventing neurodegenerative disorders and other diseases of the central nervous system. Another significant patent outlines methods of treating cancer with imidazolyl compounds, specifically targeting prostate cancer, ovarian cancer, melanoma, colorectal cancer, breast cancer, and lung cancer.
Career Highlights
Throughout his career, Moulay Alaoui-Jamali has worked with various organizations, including Osta Biotechnologies and Queen's University at Kingston. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research endeavors.
Collaborations
Moulay has collaborated with notable individuals such as Ajay Gupta and Hyman M Schipper. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Moulay Alaoui-Jamali's innovative work in the field of cancer treatment showcases his dedication to improving healthcare through scientific research. His patents reflect a commitment to developing effective therapies that can significantly impact patients' lives.